A Study Collecting Health Information to Understand and Prevent Gastric Cancer
Conditions: Gastric Atrophy; Gastric Intestinal Metaplasia; Dysplasia; Gastric Adenocarcinoma; Gastric Cancer Interventions: Behavioral: Questionnaire Sponsors: Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Breast Cancer and Breast Self-examination Education
Conditions: Breast Cancer; Breast Self-Examination Interventions: Behavioral: Education based on breast cancer and breast examination Sponsors: Sakarya University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Program of Health Behaviour Against to Cancer (PHeBAC)
Conditions: Cancer Prevention; Health Behavior; Disability, Intellectual; Parents; Cancer Screening; Experimental Study Designs; Mothers; Disabilities Mental Interventions: Behavioral: PHeBAC; Behavioral: Control Group Sponsors: Akdeniz University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer
Conditions: Oligometastatic Prostate Carcinoma; Prostate Adenocarcinoma Interventions: Drug: Abiraterone Acetate; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Biological: Gonadotropin-releasing Hormone Analog; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Other: Questionnaire Administration; Radiation: Radiation Therapy Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011
Conditions: Metastatic Breast Cancer Interventions: Diagnostic Test: 68Ga-NOTA-ABSCINT-HER2 PET/CT Sponsors: ABSCINT NV/SA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
Conditions: Triple-negative Breast Cancer Interventions: Drug: ATRA; Drug: Toripalimab Sponsors: First Affiliated Hospital of Zhejiang University; Shanghai Longfine Biotechnology Co., Ltd.; TopAlliance Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)
Conditions: SCLC, Limited Stage Interventions: Drug: Durvalumab; Drug: Chemotherapy drug of EP regimen; Radiation: radiotherapy Sponsors: Hebei Medical University Fourth Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Conditions: Cancer; Breast Cancer; Colorectal Cancer; Sarcoma; Lymphoma; Testicular Cancer Interventions: Behavioral: AYA Educational Information; Behavioral: AYA STEPS Sponsors: Duke University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Real-life Management of Patients Eligible for CAR-T Cell Therapy
Conditions: Hemopathy Interventions: Other: Patients eligible for CAR-T treatment Sponsors: University Hospital, Toulouse; Ligue contre le cancer, France; Janssen, LP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Vacuum Assisted Biopsy and Surgery Correlation in HER2 and TN Breast Cancer Subtypes MRI Responders After Neoadjuvant Therapy: BISUCO TRIAL
Conditions: Breast Cancer; Breast Biopsy Interventions: Procedure: Image guided vacuum assisted biopsy Sponsors: Hospital Universitario 12 de Octubre Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Optimization of Management for Sporadic Bilateral Renal Cell Carcinoma
Conditions: Kidney Cancer Interventions: Procedure: Surgery treatment or local tumor destruction. Sponsors: Peking University First Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme
Conditions: Papillomavirus Infections; Early Detection of Cancer; Cervix Cancer; Self-Examination Interventions: Device: Directly mailed self-sampling kit to collect a vaginal sample; Device: Mailed self-sampling kit to collect a vaginal sample after opt-in prodecure; Diagnostic Test: Standard of care - screening in a clinical setting Sponsors: Universidade do Porto; Unidade de Sa úde Familiar de Garcia de Orta, Porto; Unidade de Saúde Familiar da Prelada, Porto; Unidade de Saúde Familiar de Cedofeita, Porto; Instituto Portugues de Oncologia, Francisco Gentil, Porto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

The Prediction Model of NAC Response for Breast Cancer Based on The Parametric Dynamics Features.
Conditions: Breast Cancer; Chemotherapy Effect; Diffusion Weighted MRI; PET Imaging; Multiparametric Magnetic Resonance Imaging Interventions: Radiation: Whole body 18F-FDG Positron Emission Tomography Sponsors: National Taiwan University Hospital; Ministry of Science and Technology, Taiwan Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Adverse Events for Free Flap Surgery in Head and Neck Cancer
Conditions: Surgical Flaps; Flap Failure Risk Factors; Hematoma Risk Factors; Thrombosis Risk Factors Interventions: Procedure: Free Flap surgery Sponsors: Kaohsiung Medical University; Kaohsiung Medical University Chung-Ho Memorial Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Neo-Sequence 2 :NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC
Conditions: Gastric Cancer; Diffuse Type Carcinoma Interventions: Drug: Albumin paclitaxel+SOX+BEV+ PD-1 monoclonal antibody therapy Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials